Microsatellite polymorphism in the fibrillin 3 gene and susceptibility to PCOS: A case-control study and meta-analysis

Reproductive BioMedicine Online

Volumn 26, Issue 2, 2013, Pages 168-174

  Xie, Guang Bin ^a   Xu, Pei ^a   Che, Ye Na ^a   Xia, Yan Jie ^a   Cao, Yun Xia ^b   Wang, Wen Jun ^c   Qiao, Di ^d   Wu, Xiao Ke ^e   Yi, Long ^a   Gao, Qian ^a   Wang, Yong ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^d Jiangsu Province Geriatric Hospital   (China)

^e HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

fibrillin; genetic polymorphism; microsatellite repeats; ovary; polycystic ovary syndrome

Indexed keywords

FIBRILLIN; FIBRILLIN 3; UNCLASSIFIED DRUG;

ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; OVARY POLYCYSTIC DISEASE;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; DINUCLEOTIDE REPEATS; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICROFILAMENT PROTEINS; POLYCYSTIC OVARY SYNDROME;

EID: 84873405393     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2012.10.014     Document Type: Article

References (28)

1. R. Azziz, E. Carmina, D. Dewailly, E. Diamanti-Kandarakis, H.F. Escobar-Morreale, W. Futterweit, O.E. Janssen, R.S. Legro, R.J. Norman, A.E. Taylor, and S.F. Witchel The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report Fertil. Steril. 91 2009 456 488
2. J.A. Barry, A.R. Kuczmierczyk, and P.J. Hardiman Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis Hum. Reprod. 26 2011 2442 2451
3. H.J. Cho, I. Meira-Lima, Q. Cordeiro, L. Michelon, P. Sham, H. Vallada, and D.A. Collier Population-based and family-based studies on the serotonin transporter gene polymorphisms and bipolar disorder: a systematic review and meta-analysis Mol. Psychiatry 10 2005 771 781
4. L.W. Cho, H.S. Randeva, and S.L. Atkin Cardiometabolic aspects of polycystic ovarian syndrome Vasc. Health Risk Manag. 3 2007 55 63
5. G.M. Corson, N.L. Charbonneau, D.R. Keene, and L.Y. Sakai Differential expression of fibrillin-3 adds to microfibril variety in human and avian, but not rodent, connective tissues Genomics 83 2004 461 472
6. E. Diamanti-Kandarakis Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications Expert Rev. Mol. Med. 10 2008 e3
7. D.A. Ehrmann Polycystic ovary syndrome N. Engl. J. Med. 352 2005 1223 1236
8. K.G. Ewens, D.R. Stewart, W. Ankener, M. Urbanek, J.M. McAllister, C. Chen, K.M. Baig, S.C. Parker, E.H. Margulies, R.S. Legro, A. Dunaif, J.F. Strauss 3rd, and R.S. Spielman Family-based analysis of candidate genes for polycystic ovary syndrome J. Clin. Endocrinol. Metab. 95 2010 2306 2315
9. B.C.J.M. Fauser, B.C. Tarlatzis, R.W. Rebar, R.S. Legro, A.H. Balen, R. Lobo, E. Carmina, J. Chang, B.O. Yildiz, J.S.E. Laven, J. Boivin, F. Petraglia, C.N. Wijeyeratne, R.J. Norman, A. Dunaif, S. Franks, R.A. Wild, D. Dumesic, and K. Barnhart Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group Fertil. Steril. 97 2012 28 38.e25
10. M.O. Goodarzi Looking for polycystic ovary syndrome genes: rational and best strategy Semin. Reprod. Med. 26 2008 5 13
11. M.O. Goodarzi, D.A. Dumesic, G. Chazenbalk, and R. Azziz Polycystic ovary syndrome: etiology, pathogenesis and diagnosis Nat. Rev. Endocrinol. 7 2011 219 231
12. Group, T.R.E.A.-S.P.C.W.; 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril.; 81, 19-25.
13. C.D. Jordan, S.D. Bohling, N.L. Charbonneau, and L.Y. Sakai Fibrillins in adult human ovary and polycystic ovary syndrome: is fibrillin-3 affected in PCOS? J. Histochem. Cytochem. 58 2010 903 915
14. R.S. Legro, D. Driscoll, J.F. Strauss 3rd, J. Fox, and A. Dunaif Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome Proc. Natl. Acad. Sci. USA 95 1998 14956 14960
15. K.E. Lohmueller, C.L. Pearce, M. Pike, E.S. Lander, and J.N. Hirschhorn Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease Nat. Genet. 33 2003 177 182
16. T. Nagase, M. Nakayama, D. Nakajima, R. Kikuno, and O. Ohara Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro DNA Res. 8 2001 85 95
17. F.R. Perez-Lopez, L. Larrad-Mur, A. Kallen, P. Chedraui, and H.S. Taylor Review: gender differences in cardiovascular disease: hormonal and biochemical influences Reprod. Sci. 17 2010 511 531
18. M.J. Prodoehl, N. Hatzirodos, H.F. Irving-Rodgers, Z.Z. Zhao, J.N. Painter, T.E. Hickey, M.A. Gibson, W.E. Rainey, B.R. Carr, H.D. Mason, R.J. Norman, G.W. Montgomery, and R.J. Rodgers Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries Mol. Hum. Reprod. 15 2009 829 841
19. L. Sabatier, N. Miosge, D. Hubmacher, G. Lin, E.C. Davis, and D.P. Reinhardt Fibrillin-3 expression in human development Matrix Biol. 30 2011 43 52
20. L.R. Sorbara, Z. Tang, A. Cama, J. Xia, E. Schenker, R.A. Kohanski, L. Poretsky, E. Koller, S.I. Taylor, and A. Dunaif Absence of insulin receptor gene mutations in three insulin-resistant women with the polycystic ovary syndrome Metabolism 43 1994 1568 1574
21. D.R. Stewart, B.A. Dombroski, M. Urbanek, W. Ankener, K.G. Ewens, J.R. Wood, R.S. Legro, J.F. Strauss 3rd, A. Dunaif, and R.S. Spielman Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity J. Clin. Endocrinol. Metab. 91 2006 4112 4117
22. J.A. Talbot, E.J. Bicknell, M. Rajkhowa, A. Krook, S. O'Rahilly, and R.N. Clayton Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome J. Clin. Endocrinol. Metab. 81 1996 1979 1983
23. S. Tucci, W. Futterweit, E.S. Concepcion, D.A. Greenberg, R. Villanueva, T.F. Davies, and Y. Tomer Evidence for association of polycystic ovary syndrome in caucasian women with a marker at the insulin receptor gene locus J. Clin. Endocrinol. Metab. 86 2001 446 449
24. M. Urbanek, R.S. Legro, D.A. Driscoll, R. Azziz, D.A. Ehrmann, R.J. Norman, J.F. Strauss 3rd, R.S. Spielman, and A. Dunaif Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin Proc. Natl. Acad. Sci. USA 96 1999 8573 8578
25. M. Urbanek, A. Woodroffe, K.G. Ewens, E. Diamanti-Kandarakis, R.S. Legro, J.F. Strauss 3rd, A. Dunaif, and R.S. Spielman Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2 J. Clin. Endocrinol. Metab. 90 2005 6623 6629
26. M. Urbanek, S. Sam, R.S. Legro, and A. Dunaif Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype J. Clin. Endocrinol. Metab. 92 2007 4191 4198
27. G. Villuendas, H.F. Escobar-Morreale, F. Tosi, J. Sancho, P. Moghetti, and J.L. San Millan Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndrome Fertil. Steril. 79 2003 219 220
28. Zawadzki, J.K.; Danif, A.; 1992. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif, A.; Givens, J.R.; Haseltine, F.P.; Merriam, G.R. (Eds.), Polycystic Ovary Syndrome. Boston, Blackwell Scientific Publications.